Form 4: Molina Healthcare Director Acquires Shares

Molina Healthcare Director Stephen H. Lockhart acquired 285 shares of common stock as part of his quarterly equity award.

Summary

• Stephen H. Lockhart, a Director at Molina Healthcare, Inc. (MOH), acquired 285 shares of common stock.
• The transaction occurred on October 1, 2025, at a price of $192.79 per share.
• This acquisition was a grant under the company's 2025 Equity Incentive Plan, related to his services as a Director.
• The grant represents a quarterly portion ($55,000) of the annual $220,000 equity award for directors.
• Following this transaction, Lockhart directly owns 3,425 shares of Molina Healthcare common stock.

Sentiment

Score: 7

Explanation: Routine director equity grant, aligning interests with shareholders, which is generally viewed positively.

Positives

• Director Stephen H. Lockhart increased his direct beneficial ownership in Molina Healthcare by 285 shares.
• The acquisition aligns director interests with shareholder interests through equity compensation.

Negatives

• NA

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

This is a standard equity compensation practice for directors in publicly traded companies, aligning their interests with long-term shareholder value.

Comparison to Industry Standards

• Equity compensation for directors is a common practice across the healthcare industry and broader public markets, aiming to incentivize long-term performance and align interests with shareholders.
• The specific value of the award ($220,000 annually, $55,000 quarterly) is within typical ranges for non-executive directors at companies of similar market capitalization and complexity to Molina Healthcare, Inc.

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• The equity grant to Director Stephen H. Lockhart constitutes a related party transaction, which is a standard component of director compensation packages.

Stakeholder Impact

• Shareholders: Increased alignment of director interests with shareholder value through equity ownership.
• Management: Reinforces the company's compensation structure for non-executive directors.

Next Steps

• Future quarterly equity grants to directors are expected to continue under the 2025 Equity Incentive Plan.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled equity grant to a director as part of their compensation. It does not contain new information that would fundamentally alter the investment thesis for Molina Healthcare, Inc. While director ownership alignment is generally positive, this specific transaction is expected and does not warrant a change in investment recommendation.

Keywords

Molina Healthcare, MOH, Stephen Lockhart, Director, Stock Acquisition, Equity Incentive Plan, Insider Transaction, Form 4